X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (92) 92
humans (89) 89
male (69) 69
middle aged (57) 57
aged (56) 56
oncology (56) 56
female (49) 49
bladder cancer (46) 46
prostate cancer (43) 43
cancer (39) 39
aged, 80 and over (36) 36
urology & nephrology (35) 35
urinary bladder neoplasms - pathology (33) 33
adult (30) 30
urology (28) 28
care and treatment (26) 26
research article (23) 23
survival (23) 23
urothelial carcinoma (23) 23
research (22) 22
animals (21) 21
medical research (21) 21
tumors (20) 20
cell line, tumor (18) 18
diagnosis (18) 18
patients (18) 18
retrospective studies (18) 18
urine (18) 18
cancer therapies (17) 17
chemotherapy (17) 17
mice (17) 17
prognosis (17) 17
analysis (16) 16
diseases of the genitourinary system. urology (16) 16
surgery (16) 16
carcinoma (15) 15
immunohistochemistry (15) 15
treatment outcome (15) 15
biopsy (13) 13
expression (13) 13
sensitivity and specificity (13) 13
bladder (12) 12
medicine (12) 12
metastasis (12) 12
progression (12) 12
prostate (12) 12
proteins (12) 12
recurrence (12) 12
risk factors (12) 12
studies (12) 12
therapy (12) 12
biomarkers (11) 11
cancer research (11) 11
health aspects (11) 11
medicine & public health (11) 11
radiation therapy (11) 11
urinary bladder (11) 11
angiogenesis (10) 10
antigens (10) 10
bladder-cancer (10) 10
disease-free survival (10) 10
medical prognosis (10) 10
multivariate analysis (10) 10
neoplasm staging (10) 10
outcomes (10) 10
prostatic neoplasms - radiotherapy (10) 10
radiotherapy (10) 10
urinary bladder neoplasms - diagnosis (10) 10
urinary bladder neoplasms - urine (10) 10
usage (10) 10
5-aminolevulinic acid (9) 9
biomarkers, tumor - urine (9) 9
enzyme-linked immunosorbent assay (9) 9
follow-up studies (9) 9
medicine, research & experimental (9) 9
neoplasm invasiveness (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
transitional-cell carcinoma (9) 9
urogenital system (9) 9
cytokines (8) 8
gene expression (8) 8
inflammation (8) 8
medical colleges (8) 8
medicine, experimental (8) 8
men (8) 8
neoplasm grading (8) 8
prostate-cancer (8) 8
prostate-specific antigen - blood (8) 8
prostatic neoplasms - pathology (8) 8
radical prostatectomy (8) 8
renal cell carcinoma (8) 8
urinary bladder neoplasms - genetics (8) 8
urinary bladder neoplasms - metabolism (8) 8
urinary bladder neoplasms - surgery (8) 8
aminolevulinic acid (7) 7
apoptosis (7) 7
development and progression (7) 7
disease models, animal (7) 7
drug therapy (7) 7
follow-up (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Science, ISSN 1347-9032, 11/2017, Volume 108, Issue 11, pp. 2221 - 2228
Journal Article
BMC Research Notes, ISSN 1756-0500, 02/2019, Volume 12, Issue 1, pp. 72 - 4
Urine production is regulated throughout the night to ensure that it remains within functional bladder capacity. Increasing bladder capacity may thus play an... 
Rat | AVP | Bladder distention | Arginine | Enzymes | Vasopressin | Urine | Medical research | Immunoassay | Daytime | Argipressin | Secretion | Bladder | Urethane | Enzyme immunoassay | Experiments | Nighttime | Urology | Distension | Sleep | Software | Intubation | Laboratory animals
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 05/2014, Volume 105, Issue 5, pp. 616 - 622
Journal Article
BMC Research Notes, ISSN 1756-0500, 05/2018, Volume 11, Issue 1, pp. 342 - 5
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e96705
Intravesical Bacillus Calmette-Guerin (BCG) has been shown to induce a specific immunologic response (i.e., activation of IL-2 and effector T-cells), while... 
BACILLUS-CALMETTE-GUERIN | N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE | IMMUNOTHERAPY | UROTHELIAL CARCINOMA | MITOMYCIN-C | INTERLEUKIN-15 | MULTIDISCIPLINARY SCIENCES | IL-15 | GENE-THERAPY | STAGE-TA | EXPRESSION | Mycobacterium bovis - immunology | Rats | Urinary Bladder - immunology | Antineoplastic Agents - therapeutic use | Urinary Bladder - pathology | Urinary Bladder Neoplasms - drug therapy | Rats, Sprague-Dawley | Urinary Bladder Neoplasms - chemically induced | Proteins - therapeutic use | Animals | Tumor Burden - drug effects | Urinary Bladder Neoplasms - immunology | Urinary Bladder Neoplasms - pathology | Killer Cells, Natural - immunology | Female | Urinary Bladder - drug effects | Antineoplastic Agents - pharmacology | Proteins - pharmacology | Administration, Intravesical | Cytokines - biosynthesis | Disease Models, Animal | Production management | Killer cells | Cytokines | Models | T cells | Drug therapy | Health aspects | Bladder cancer | Tumors | Cell proliferation | Health sciences | RANTES | CD8 antigen | Clinical trials | Bladder | Effector cells | Activation | Lymphocytes T | Tissues | Cancer therapies | Angiogenesis | Reduction | Carcinogens | Interleukin 2 | Urinary bladder | Lymphocytes | Immunotherapy | Natural killer cells | Medical research | Antigens | Secretion | Invasiveness | Neutrophils | BCG | Muscles | Radioactive half-life | Pharmacology | Interleukin 15 | Gene expression | Chemical compounds | Biological activity | Antitumor activity | Gene therapy | Cancer
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0175494
Intravesical bacillus Calmette-Guerin (BCG) treatment is the most common therapy to prevent progression and recurrence of non-muscle invasive bladder cancer... 
SURVIVAL | BACILLUS-CALMETTE-GUERIN | THERAPY | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | GROWTH | REGULATORY T-CELLS | SUPPRESSOR-CELLS | CARCINOMA | TUMOR-IMMUNITY | GEMCITABINE | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Deoxycytidine - pharmacology | Urinary Bladder Neoplasms - chemically induced | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neoplasms, Experimental - immunology | Butylhydroxybutylnitrosamine - adverse effects | Female | Gene Expression Regulation, Neoplastic - drug effects | Doxorubicin - administration & dosage | Cytokines - metabolism | Deoxycytidine - administration & dosage | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Mitomycin - pharmacology | Animals | Urinary Bladder Neoplasms - immunology | Mice | Administration, Intravesical | Mitomycin - administration & dosage | Neoplasms, Experimental - drug therapy | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology | Antimitotic agents | Care and treatment | Dosage and administration | Antineoplastic agents | Bladder cancer | Immune response | Cytokines | Lung cancer | Lymphocytes T | Cancer therapies | Urology | Chemotherapy | Immunotherapy | Ligands | Tumor necrosis factor-TNF | Laboratory animals | Immune system
Journal Article